Long-term effectiveness of Radiofrequency Ablation for solitary small Hepatocellular Carcinoma: A retrospective analysis of 363 patients

Digestive and Liver Disease

Volumn 45, Issue 4, 2013, Pages 336-341

  Francica, Giampiero ^a   Saviano, Antonio ^b   De Sio, Ilario ^c   De Matthaeis, Nicoletta ^b   Brunello, Franco ^d   Cantamessa, Alessandro ^d   Giorgio, Antonio ^e   Scognamiglio, Umberto ^e   Fornari, Fabio ^f   Giangregorio, Francesco ^f   Piscaglia, Fabio ^g   Gualandi, Silvia ^g   Caturelli, Eugenio ^h   Roselli, Paola ^h   Rapaccini, Gian Ludovico ^b   Pompili, Maurizio ^b  

^a S Maria della Pietà Camilliani Hospital   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d MOLINETTE HOSPITAL   (Italy)

^e Azienda Ospedaliera di Rilievo Nazionale D Cotugno   (Italy)

^f Piacenza Hospital   (Italy)

^g UNIVERSITY OF BOLOGNA   (Italy)

^h BELCOLLE HOSPITAL   (Italy)

Author keywords

Cirrhosis; Liver tumour ablation

Indexed keywords

ANALGESIC AGENT;

AGE DISTRIBUTION; AGED; ARTICLE; ASCITES; CANCER MORTALITY; CANCER SIZE; CANCER SURVIVAL; CHILD PUGH SCORE; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FEMALE; FEVER; HEMOPERITONEUM; HUMAN; LIVER ABSCESS; LIVER CELL CARCINOMA; LIVER HEMATOMA; LIVER NECROSIS; LIVER NODULE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PAIN; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

AGE FACTORS; AGED; ASCITES; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; ODDS RATIO; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 84875396149     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2012.10.022     Document Type: Article

References (43)

1. El-Serag H.B., Rudolph K.L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007, 132:2557-2576.
2. Bruix J., Sherman M., Llovet J.M., et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. Journal of Hepatology 2001, 35:421-430.
3. Bruix J., Sherman M. Management of hepatocellular carcinoma. Hepatology 2005, 42:1208-1236. Practice Guidelines Committee AASLD or American Association for the Study of Liverd Disease.
4. Bruix J., Sherman M. Management of hepatocellular carcinoma: an update. Hepatology 2011, 53:1020-1022. American Association for the Study of Liver Disease.
5. Santi V., Buccione D., Di Micoli A., et al. The changing scenario of hepatocellular carcinoma over the last two decades in Italy. Journal of Hepatology 2012, 56:397-405.
6. Gervais D.A., Arellano R.S. Percutaneous tumor ablation for hepatocellular carcinoma. American Journal of Roentgenology 2011, 197:789-794.
7. Lencioni R., Crocetti L. Local-regional treatment of hepatocellular carcinoma. Radiology 2012, 262:43-58.
8. Cho Y.K., Kim J.K., Kim M.Y., et al. Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology 2009, 49:453-459.
9. European Association For The Study Of The Liver; European Organisation For Research And Treatment Of Cancer EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. Journal of Hepatology 2012, 56:908-943.
10. Omata M., Lesmana L.A., Tateishi R., et al. Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma. Hepatology International 2010, 4:439-474.
11. Choi D., Lim H.K., Rhim H., et al. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. European Radiology 2007, 17:684-692.
12. Livraghi T., Meloni F., Di Stasi M., et al. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?. Hepatology 2008, 47:82-89.
13. N'Kontchou G., Mahamoudi A., Aout M., et al. Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis. Hepatology 2009, 50:1475-1483.
14. Livraghi T. Radiofrequency ablation of hepatocellular carcinoma. Surgical Oncology Clinics of North America 2011, 20:281-299. viii.
15. de Lope C.R., Tremosini S., Forner A., et al. Management of HCC. Journal of Hepatology 2012, 56(Suppl. 1):S75-S87.
16. Forner A., Llovet J.M., Bruix J. Hepatocellular carcinoma. Lancet 2012, 379:1245-1255.
17. Sacks D., McClenny T.E., Cardella J.F., et al. Society of Interventional Radiology clinical practice guidelines. Journal of Vascular and Interventional Radiology 2003, 14:S199-S202.
18. Goldberg S.N., Grassi C.J., Cardella J.F., et al. Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 2005, 235:728-739.
19. Lencioni R.A., Allgaier H.P., Cioni D., et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection. Radiology 2003, 228:235-240.
20. Lin S.M., Lin C.J., Lin C.C., et al. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4cm. Gastroenterology 2004, 127:1714-1723.
21. Lin S.M., Lin C.J., Lin C.C., et al. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3cm or less. Gut 2005, 54:1151-1156.
22. Shiina S., Teratani T., Obi S., et al. A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma. Gastroenterology 2005, 129:122-130.
23. Brunello F., Veltri A., Carucci P., et al. Radiofrequency ablation versus ethanol injection for early hepatocellular carcinoma: A randomized controlled trial. Scandinavian Journal of Gastroenterology 2008, 43:727-735.
24. Germani G., Pleguezuelo M., Gurusamy K., et al. Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis. Journal of Hepatology 2010, 52:380-388.
25. Zhou Y., Zhao Y., Li B., et al. Meta-analysis of radiofrequency ablation versus hepatic resection for small hepatocellular carcinoma. BMC Gastroenterol 2010, 10:78.
26. Llovet J.M., Bru C., Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Seminars in Liver Disease 1999, 19:329-338.
27. Sala M., Llovet J.M., Vilana R., et al. Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 2004, 40:1352-1360.
28. Pacella C.M., Francica G., Di Lascio F.M., et al. Long-term outcome of cirrhotic patients with early hepatocellular carcinoma treated with ultrasound-guided percutaneous laser ablation: a retrospective analysis. Journal of Clinical Oncology 2009, 27:2615-2621.
29. Livraghi T., Solbiati L., Meloni M.F., et al. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003, 226:441-451.
30. Rossi S., Ravetta V., Rosa L., et al. Repeated radiofrequency ablation for management of patients with cirrhosis with small hepatocellular carcinomas: a long-term cohort study. Hepatology 2011, 53:136-147.
31. Shiina S., Tateishi R., Arano T., et al. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. American Journal of Gastroenterology 2012, 107:569-577.
32. Takayama T., Makuuchi M., Hirohashi S., et al. Early hepatocellular carcinoma as an entity with a high rate of surgical cure. Hepatology 1998, 28:1241-1246.
33. Yamamoto M., Takasaki K., Otsubo T., et al. Favorable surgical outcomes in patients with early hepatocellular carcinoma. Annals of Surgery 2004, 239:395-399.
34. Minagawa M., Ikai I., Matsuyama Y., et al. Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13,772 patients in Japan. Annals of Surgery 2007, 245:909-922.
35. Lu M.D., Kuang M., Liang L.J., et al. Surgical resection versus percutaneous thermal ablation for early-stage hepatocellular carcinoma: a randomized clinical trial. Zhonghua Yi Xue Za Zhi 2006, 86:801-805.
36. Chen M.S., Li J.Q., Zheng Y., et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Annals of Surgery 2006, 243:321-328.
37. Feng K., Yan J., Li X., et al. A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. Journal of Hepatology 2012, 57:794-802.
38. Francica G., Petrolati A., Di Stasio E., et al. Influence of ablative margin on local tumor progression and survival in patients with HCC≦4cm after laser ablation. Acta Radiologica 2012, 53:394-400.
39. Mazzaferro V., Battiston C., Perrone S., et al. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Annals of Surgery 2004, 240:900-909.
40. Lu D.S., Yu N.C., Raman S.S., et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology 2005, 41:1130-1137.
41. Pompili M., Mirante V.G., Rondinara G., et al. Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: assessment of efficacy at explant analysis and of safety for tumor recurrence. Liver Transplantation 2005, 11:1117-1126.
42. Berber E., Siperstein A. Local recurrence after laparoscopic radiofrequency ablation of liver tumors: an analysis of 1032 tumors. Annals of Surgical Oncology 2008, 15:2757-2764.
43. Poon R.T., Fan S.T., Ng I.O., et al. Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical reappraisal. Annals of Surgery 2000, 231:544-551.